Population
Blood-brain barrier microvessel endothelial cells (MECs)
Comparison
Angiotensin II for 0 to 6 hours, with or without… vs Control or Angiotensin II alone
Design
Preclinical
Follow-up
6 hours
Authors
Loading...
AT1 blockade may limit BBB permeability in hypertensive models; leaves open translation to human encephalopathy prevention.
Angiotensin II directly increases blood-brain barrier permeability via AT1 receptor activation, providing a potential mechanistic explanation for hypertensive encephalopathy.
Fleegal-DeMotta et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: